Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review

GlobalData
January 27, 2015
17 Pages - SKU: GBDT5474994
Napp Pharmaceuticals Limited - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Napp Pharmaceuticals Limited (Napp Pharmaceuticals) is a UK-based pharmaceutical company. It researches, develops and manufactures drugs for various therapeutic areas including pain management, oncology, respiratory, rheumatology, and cardiovascular, with special focus on pain management and oncology. The company’s product portfolio includes BuTrans, OxyNorm, and Targinact, among others for pain management; DepoCyte and Levact for the treatment of cancer; flutiform, Phyllocontin and Uniphyllin, among others for respiratory indications; Lodotra for the treatment of rheumatic diseases; and Adizem for gastrointestinal and cardiovascular indications.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.



More Pharmaceuticals Company reports by GlobalData

Orifarm Group AS - Strategic SWOT Analysis Review by GlobalData
Orifarm Group AS - Strategic SWOT Analysis Review- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report ...
Sareum Holdings plc (SAR) - Financial and Strategic SWOT Analysis Review by GlobalData
Sareum Holdings plc (SAR) - Financial and Strategic SWOT Analysis Review- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. ...
Par Pharmaceutical Companies, Inc. - Strategic SWOT Analysis Review by GlobalData
Par Pharmaceutical Companies, Inc. - Strategic SWOT Analysis Review- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The ...
Pacira Pharmaceuticals, Inc. (PCRX) - Financial and Strategic SWOT Analysis Review by GlobalData
Pacira Pharmaceuticals, Inc. (PCRX) - Financial and Strategic SWOT Analysis Review- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 125  
    Site License  USD 250  
    Global Site License  USD 375  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!